Abstract
Using ab initio methods, we have studied conformations of the de(sidechain)de(dioxy)difluoroepothilone model to quantify the effect of stability change between the exo and endo conformers of the epoxy ring. The DFT minimization of the macrolactone ring reveals four low energy conformers, although MP2 predicted five stable structures. The model tested with DFT hybride functional (B3LYP/6–31+G(d,p)) exhibits the global minimum for one of the exo forms (C), experimentally observed in the solid state, but unexpectedly with the MP2 electron correlation method for the virtual endo form (W). Using the QST3 technique, several pathways were found for the conversion of the low energy conformers to the other low energy exo representatives, as well as within the endo analog subset. The potential energy relationships obtained for several exo forms suggest a high conformational mobility between three, experimentally observed, conformers. The high rotational barrier, however, excludes direct equilibrium with experimental EC-derived endo form S. The highest calculated transition state for the conversion of the most stable exo M interligand to the endo S form is approximately a 28 kcal/mol above the energy of the former. The two-step interconversion of the exo H conformer to the endo S requires at least 28 kcal/mol. Surprisingly, we found that the transition state energy of the H form to the virtual endo W has the acceptable value of about 9 kcal/mol and the next energy barrier for free interconversion of endo W to endo S is 13 kcal/mol.

DFT Model of Epothilone Interconversions



Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Altmann K-H, Gertsch J (2007) Anticancer drugs from nature-natural products as a unique source of new microtubule-stabilizing agents. Nat Prod Rep 24:327–357
Jordan MA (2002) Mechanism of action of antitumor drugs that interact with microtubules and tubulin. Curr Med Chem Anti-Cancer Agents 2:1–17
Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4:253–265
Snyder JP, Nettles JH, Cornett B, Downing KH, Nogales E (2001) The binding conformation of Taxol in β-tubulin: a model based on electron crystallographic density. Proc Natl Acad Sci USA 98:5312–5316
Löwe J, Li H, Downing KH, Nogales E (2001) Refined structure of α-beta tubulin from zinc-induced sheets stabilized with taxol. J Mol Biol 313:1045–1057
Johnson SA, Alcaraz AA, Snyder JP (2005) T-Taxol and the electron crystallographic density in β-tubulin. Org Lett 7:5549–5552
Kingston DGI, Bane S, Snyder JP (2005) The taxol pharmacophore and the T-taxol bridging principle. Cell Cycle 4:279–289
DE 4138042 1993 (1993) Chem Abstr 120:52841
Gerth K, Bedorf N, Höfle G, Irschik H, Reichenbach H (1996) Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). J Antibiot 49:560–563
Höfle G, Bedorf N, Steinmetz H, Schomburg D, Gerth K, Reichenbach H (1996) Epothilone A and B - novel 16-membered macrolides with cytotoxic activity: isolation, crystal structure, and conformation in solution. Angew Chem Int Ed 35:1567–1569
Bollag DM, McQueney PA, Zhu J, Hensens O, Koupal L, Liesch J, Goetz M, Lazarides E, Woods CM (1995) Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action. Cancer Res 55:2325–2333
Nicolaou KC, Roschangar F, Vourloumis D (1998) Chemical biology of epothilones. Angew Chem Int Ed 37:2014–2045
Nicolaou KC, Ritzén A, Namoto K (2001) Recent developments in the chemistry, biology and medicine of the epothilones. Chem Commun 1523–1535
Altmann K-H (2004) The merger of natural product synthesis and medicinal chemistry: on the chemistry and chemical biology of epothilones. Org Biomol Chem 2:2137–2152
Borzilleri RM, Vite GD (2002) Epothilones: new tubulin polymerization agents in preclinical and clinical development. Drugs Fut 27:1149–1163
Altmann K-H (2005) Recent developments in the chemical biology of epothilones. Curr Pharm Des 11:1595–1613
Borzilleri RM, Zheng X, Schmidt RJ, Johnson JA, Kim S-H, DiMarco JD, Fairchild CR, Gougoutas JZ, Lee FYF, Long BH, Vite GD (2000) A novel application of a Pd(0)-catalyzed nucleophilic substitution reaction to the regio- and stereoselective synthesis of lactam analogues of the epothilone natural products. J Am Chem Soc 122:8890–8897
Gianni L (2007) Ixabepilone and the narrow path to developing new cytotoxic drugs. J Clin Oncol 25:3389–3391
De Jonge M, Verweij J (2005) The epothilone dilemma. J Clin Oncol 23:9048–9050
Nettles JH, Li H, Cornett B, Krahn JM, Snyder JP, Downing KH (2004) The binding mode of epothilone A on α,β-tubulin by electron crystallography. Science 305:866–869
Winkler JD, Axelsen PH (1996) A model for the taxol (paclitaxel)/epothilone pharmacophore. Bioorg Med Chem Lett 6:2963–2966
Ojima I, Chakravarty S, Inoue T, Lin S, He L, Horwitz SB, Kuduk SD, Danishefsky SJ (1999) A common pharmacophore for cytotoxic natural products that stabilize microtubules. Proc Natl Acad Sci USA 96:4256–4261
Giannakakou P, Gussio R, Nogales E, Downing KH, Zaharevitz D, Bollbuck B, Poy G, Sackett D, Nicolaou KC, Fojo T (2000) A common pharmacophore for epothilone and taxanes: molecular basis for drug resistance conferred by tubulin mutations in human cancer cells. Proc Natl Acad Sci USA 97:2904–2909
He L, Jagtap PG, Kingston DG I, Shen H-J, Orr GA, Horwitz SB (2000) A common pharmacophore for taxol and the epothilones based on the biological activity of a taxane molecule lacking a C-13 side chain. Biochemistry 39:3972–3978
Lee KW, Briggs JM (2001) Comparative molecular field analysis (CoMFA) study of epothilones-tubulin depolymerization inhibitors: pharmacophore development using 3D QSAR methods. J Comput-Aided Mol Design 15:41–55
Manetti F, Maccari L, Corelli F, Botta M (2004) 3D QSAR models of interactions between β-tubulin and microtubule stabilizing antimitotic agents (MSAA): a survey on taxanes and epothilones. CurrTop MedChem 4:203–217
Day BW (2000) Mutants yield a pharmacophore model for the tubulin-paclitaxel binding site. Trends Pharmacol Sci 21:321–323
Taylor RE, Zajicek J (1999) Conformational properties of epothilone. J Org Chem 64:7224–7228
Carlomagno T, Blommers MJJ, Meiler J, Jahnke W, Schupp T, Petersen F, Schinzer D, Altmann K-H, Griesinger C (2003) The high-resolution solution structure of epothilone a bound to tubulin: an understanding of the structure-activity relationships for a powerful class of antitumor agents. Angew Chem Int Ed 42:2511–2515
Carlomagno T, Sánchez VM, Blommers MJJ, Griesinger C (2003) Derivation of dihedral angles from CH-CH dipolar-dipolar cross-correlated relaxation rates: a C-C torsion involving a quaternary carbon atom in epothilone A bound to tubulin. Angew Chem Int Ed Engl 42:2515–2517
Reese M, Sánchez-Pedregal VM, Kubicek K, Meiler J, Blommers MJJ, Griesinger C, Carlomagno T (2007) Structural basis of the activity of the microtubule-stabilizing agent epothilone a studied by NMR spectroscopy in solution. Angew Chem Int Ed 46:1864–1868
Ballone P, Marchi M (1999) A density functional study of a new family of anticancer drugs: paclitaxel, taxotere, epothilone, and discodermolide. J Phys Chem A 103:3097–3102
Bondi A (1964) van der Waals volumes and radii. J Phys Chem 68:441–451
Jolly WL, Perry WB (1973) Estimation of atomic charges by an electronegativity equalization procedure calibrated with core binding energies. J Am Chem Soc 95:5442–5450
Jolly WL, Perry WB (1974) Calculation of atomic charges by an electronegativity equalization procedure. Inorg Chem 13:2686–2692
Huheey JE, Keiter EA, Keiter RL (1993) Inorganic chemistry: principles of structure and reactivity, 4th edn. Harper Collins, New York
James AM, Lord MP (1992) Macmillan’s chemical and physical data. Macmillan, London
Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Montgomery JA, Vreven T, Kudin KN, Burant JC, Millam JM, Iyengar SS, Tomasi J, Barone V, Mennucci B, Cossi M, Scalmani G, Rega N, Petersson GA, Nakatsuji H, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Klene M, Li X, Knox JE, Hratchian HP, Cross JB, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Ayala PY, Morokuma K, Voth GA, Salvador P, Dannenberg JJ, Zakrzewski VG, Dapprich S, Daniels AD, Strain MC, Farkas O, Malick DK, Rabuck AD, Raghavachari K, Foresman JB, Ortiz JV, Cui Q, Baboul AG, Clifford S, Cioslowski J, Stefanov BB, Liu G, Liashenko A, Piskorz P, Komaromi I, Martin RL, Fox DJ, Keith T, Al-Laham MA, Peng CY, Nanayakkara A, Challacombe M, Gill PMW, Johnson B, Chen W, Wong MW, Gonzalez C, Pople JA (2004) Gaussian 03 Revision C02 Gaussian Inc, Wallingford CT
Becke AD (1988) Density-functional exchange-energy approximation with correct asymptotic behavior. Phys Rev A 38:3098–3100
Møller C, Plesset MS (1934) Note on an approximation treatment for many-electron systems. Phys Rev 46:618–622
Wang M, Xia X, Kim Y, Hwang D, Jansen JM, Botta M, Liotta DC, Snyder JP (1999) A unified and quantitative receptor model for the microtubule binding of paclitaxel and epothilone. Org Lett 1:43–46
Manetti F, Forli S, Maccari L, Corelli F, Botta M (2003) 3D QSAR studies of the interaction between β-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones. Il Farmaco 58:357–361
CSD: The Cambridge Structural Database Cambridge Crystallographic Data Centre 12 Union Road Cambridge CB21EZ UK, www.ccdc.cam.ac.uk
Nagano S, Li H, Shimizu H, Nishida C, Ogura H, Ortiz de Montellano PR, Poulos TL (2003) Crystal structures of epothilone D-bound, epothilone B-bound, and substrate-free forms of cytochrome P450epoK. J Biol Chem 278:44886–44893
Peng C, Schlegel HB (1993) Combining synchronous transit and quasi-Newton methods to find transition states. Isr J Chem 33:449–454
Peng C, Ayala PY, Schlegel HB, Frisch MJ (1996) Using redundant internal coordinates to optimize equilibrium geometries and transition states. J Comput Chem 17:49–56
Taylor RE, Chen Y, Beatty A, Myles DC, Zhou Y (2003) Conformation-activity relationships in polyketide natural products: a new perspective on the rational design of epothilone analogues. J Am Chem Soc 125:26–27
Heinz DW, Schubert W-D, Höfle G (2005) Much anticipated - the bioactive conformation of epothilone and its binding to tubulin. Angew Chem Int Ed 44:1298–1301
Abraham RJ, Castellazzi I, Sancassan F, Smith TAD (1999) Conformational analysis, Part 31.1 A theoretical and lanthanide induced shift (LIS) investigation of the conformations of some epoxides. J Chem Soc Perkin Trans 2:99–106
Vila A, Mosquera RA (2003) AIM study on the protonation of methyl oxiranes. Chem Phys Lett 371:540–547
Coxon JM, Thorpe AJ, Smith WB (1999) Potential energy surface for the acid- and BF3-catalyzed rearrangement of methylpropene oxide. J Org Chem 64:9575–9586
Carlier PR, Deora N, Crawford TD (2006) Protonated 2-methyl-1,2-epoxypropane: a challenging problem for density functional theory. J Org Chem 71:1592–1597
Schweizer WB, Dunitz JD (1982) Structural characteristics of the carboxylic ester group. Helv Chim Acta 65:1547–1554
Hammond GS (1955) A correlation of reaction rates. J Am Chem Soc 77:334–338
Smith MB, March J (2007) March’s advanced organic chemistry: reactions mechanisms and structure, chapter 6, 6th edn. Wiley, New York
Eliel EL, Wilen SH (1994) Stereochemistry of organic compounds, chapter 11. Wiley, New York
Cicero DO, Barbato G, Bazzo R (1995) NMR analysis of molecular flexibility in solution: a new method for the study of complex distributions of rapidly exchanging conformations. application to a 13-residue peptide with an 8-residue loop. J Am Chem Soc 117:1027–1033
Erdelyi M, Pfeiffer B, Hauenstein K, Fohrer J, Gertsch J, Altmann K-H, Carlomagno T (2008) Conformational preferences of natural and C3-Modified epothilones in aqueous solution. J Med Chem 51:1469–1473
Acknowledgments
This study was supported by Poznan University of Technology /DS 32/045/2007. The authors are grateful to Professor M. Botta (Università degli Studi di Siena, Siena, Italy), Professor R. E. Taylor (University of Notre Dame, Notre Dame, IN), Professor J. P. Snyder and Dr M. Wang (Emory University, Atlanta, GA), Professor J. Meiler (Vanderbilt University, Nashville, TN) for providing original coordinates of conformers to prepare initial guesses for the generation of epothilone representatives. We also acknowledge Poznanskie Centrum Superkomputerowo-Sieciowe, Poland for computational time.
Author information
Authors and Affiliations
Corresponding author
Supporting information available
Tables containing energies for the optimized conformers, intermediates and transition states of epothilone A 2 derivative and their other structural data are available free of charge at doi://10.1007/s00894-008-0428-3 or from the authors.
ESM 1
(PDF 79.8 KB)
Rights and permissions
About this article
Cite this article
Rusinska-Roszak, D., Lozynski, M. De(side chain) model of epothilone: bioconformer interconversions DFT study. J Mol Model 15, 859–869 (2009). https://doi.org/10.1007/s00894-008-0428-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00894-008-0428-3


